Navigation Links
Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference
Date:9/2/2009

SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Thomas Weisel Partners Healthcare Conference in Boston.

The live presentation takes place Wednesday, September 9, 2009 at 9:45 a.m. Eastern Time (ET)/6:45 a.m. Pacific Time (PT). The presentation will be simultaneously webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

About Neurocrine

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix for Treatment of Endometriosis Pain
2. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2009 Financial Results
3. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2008 Results
4. Webcast Alert: Neurocrine Announces 1Q08 Financial Results
5. Neurocrine Announces Closing of $109 Million Sale and Leaseback Agreement for its Real Estate Assets
6. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
7. Cell Biosciences Launches Unique Protein Phosphorylation Assay Service
8. Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences(R) to Provide World-Class Fluid Management and Liquid/Powder System Solutions
9. Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics
10. Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
11. Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... Santa Rosa, CA (PRWEB) , ... January 15, ... ... to nominate their choice of best physicians in eight Bay Area counties for ... selected by the healthcare research company managing the award process. Results were announced ...
(Date:1/14/2017)... ... January 13, 2017 , ... According to a December 9 ... may lower the risk of type 2 diabetes, Alzheimer’s, and cardiovascular disease. Southern ... wellness benefits linked to a Mediterranean diet are only some of the many ...
(Date:1/13/2017)... ... 2017 , ... A January 10 article in the Daily Star ... publication, with an emphasis on some new techniques that the publication says are becoming ... more casually to his patients and colleagues as Dr. J, comments that the best ...
(Date:1/13/2017)... ... January 13, 2017 , ... People who have sensitive teeth are about ... they brush their teeth. Sadly, most dental hygiene products in the market contain chemical ... For these people, continuing their daily oral care routine to keep their teeth white ...
(Date:1/13/2017)... ... January 13, 2017 , ... The ... and most comprehensive franchise ranking. Recognized by entrepreneurs and franchisors as a top ... exceptional performance in areas including financial strength and stability, growth rate, and brand ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... , January 13, 2017 ... to see how they have fared at yesterday,s closing ... Galena Biopharma Inc. (NASDAQ: GALE ), and ... companies harness cellular and biomolecular processes to develop technologies ... our environmental footprint, feed the hungry, use less and ...
(Date:1/13/2017)... YORK , January 13, 2017 ... legal cannabis industry, with several states voting in favor of ... , the largest Cannabis market in the U.S. In addition, ... $1 billion mark in annual cannabis products sales. The ArcView ... according to which the legal cannabis sales in the U.S. ...
(Date:1/13/2017)...   JDRF , the leading global organization ... to announce that after more than a decade ... Medicaid Services (CMS) has recognized continuous glucose monitoring ... in making diabetes treatment decisions as durable medical ... for coverage under Medicare. JDRF has been the ...
Breaking Medicine Technology: